Thermogenesis Clinical Trial
— ASCENTOfficial title:
Beta 2 Adrenergic Stimulation vs Cold Exposure to Activate Human Brown Adipose Tissue
Verified date | September 2023 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to asses brown adipose tissue activity in humans after intravenous administration of the selective beta-2-adrenergic agonist fenoterol as compared to the natural activator of brown adipose tissue, a mild cold stimulus.
Status | Completed |
Enrollment | 12 |
Est. completion date | March 6, 2023 |
Est. primary completion date | March 6, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - BMI 18,5-23 kg/m2 or 30-35 kg/m2 Exclusion Criteria: - History or signs of any medical or psychological condition - pregnancy or lactation - medications except prescription free analgesics and contraceptives - habitual alcohol or tobacco use - weight change >5% within prior 3 months - Resting heart rate >85 bpm - Systolic blood pressure >140 mmHg or diastolic blood pressure <50 mmHg - Presence of following ECG changes: ST-segment deviations, QTc >500ms, signs of pre-excitation - Hyper- or Hypothyroidism - inability to follow study procedures - Enrolment of the investigator, his/her family members, employees and other dependent persons - hypersensitivity to cold - enrolment into study with ionizing radiation within prior 12 months. - Cold induced thermogenesis of less than 5% basal metabolic rate and normal weight or cold induced thermogenesis of more than 5% and overweight (determined during screening visit) |
Country | Name | City | State |
---|---|---|---|
Switzerland | University Hospital Basel, Dept. of Endocrinology | Basel |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BAT SUVmean | 18F-FDG uptake into the supra-clavicular brown adipose tissue as determined by 18F-FDG PET-CT after the respective study intervention | 30 minutes after end of intervention | |
Secondary | BAT SUVmax | maximum SUV in supraclavicular adipose tissue (according to BARCIST 1.0) | 30 minutes after intervention | |
Secondary | BAT Volume | volume of supraclavicular adipose tissue (according to BARCIST 1.0) | 30 minutes after intervention | |
Secondary | BAT glycolytic volume | volume of supraclavicular adipose tissue x SUVmean (according to BARCIST 1.0) | 30 minutes after intervention | |
Secondary | Change in energy expenditure | Quantitative change in EE above resting metabolic rate in response to the respective study intervention. Measured by indirect calorimetry. | First and last 30 minutes of intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04766021 -
Mirabegron and Physiological Function in Cold Environments
|
Phase 1/Phase 2 | |
Completed |
NCT01898949 -
Stimulation of Diet-Induced Thermogenesis by Cold-Exposure
|
N/A | |
Completed |
NCT06121817 -
Thermogenic Effect and Metabolic Responses of Durian
|
N/A | |
Completed |
NCT05990387 -
MIrabegron and Physiological Function in Cold Environments
|
Phase 1/Phase 2 |